InfuSystem to Report Q3 2025 Results on November 4
Rochester Hills, Mich., October 29, 2025 — InfuSystem Holdings, Inc. (NYSE American: INFU), a national healthcare service provider known for supporting outpatient care and durable medical equipment (DME) manufacturers, announced that it will release its financial results for the third quarter of 2025 on Tuesday, November 4, 2025, before U.S. markets open.
Following the release, the company’s management team will host a conference call at 9:00 a.m. Eastern Time to review results and discuss recent business developments.
Investors and analysts can join the call by dialing (833) 366-1127 (U.S.) or (412) 902-6773 (international). A live webcast will also be available in the Investors section of the company’s website at https://ir.infusystem.com.
A replay of the webcast will be accessible for 90 days after the event through the same website. Telephone replays can also be accessed by calling (855) 669-9658 or (412) 317-0088, using access code 7148856, through Tuesday, November 11, 2025.
Focus on Expanding Outpatient Care
InfuSystem Holdings, headquartered in Rochester Hills, Michigan, provides essential services that support outpatient treatment for patients across North America. The company operates under a dual-platform model designed to connect healthcare providers and DME manufacturers with patients who require continuous care outside hospital settings.
The two key business platforms are Patient Services and Device Solutions, both of which contribute to InfuSystem’s mission of improving the quality, accessibility, and efficiency of outpatient care.
Patient Services Platform
The Patient Services segment forms the core of InfuSystem’s operations. It acts as the “last-mile” link between healthcare providers and patients, ensuring that individuals who need specialized medical equipment can continue their treatment safely and effectively at home or in outpatient facilities.
InfuSystem’s patient services cover three main areas of therapy:
- Oncology: The company supports cancer treatment centers and oncologists by supplying infusion pumps and related services for chemotherapy and other infusion therapies. These offerings enable clinics to extend quality cancer care into outpatient settings while maintaining patient safety and compliance.
- Pain Management: InfuSystem provides infusion systems that help manage acute and chronic pain through targeted delivery mechanisms. This service allows patients to continue recovery at home without compromising care quality.
- Wound Therapy: The company also provides negative pressure wound therapy (NPWT) systems, which are used to treat complex or chronic wounds. These systems help reduce hospital stays and overall treatment costs while promoting faster healing.
Through these integrated services, InfuSystem enhances patient outcomes, reduces readmission rates, and enables healthcare providers to deliver cost-effective, high-quality care outside hospital walls.
Device Solutions Platform
The company’s Device Solutions platform complements its patient-focused services by offering equipment management and technical support to hospitals, clinics, and medical device manufacturers.
This segment includes:
- Direct Payer Rentals: InfuSystem rents infusion pumps and other durable medical equipment to healthcare providers, giving them flexible access to vital tools without large capital costs.
- Pump and Consumable Sales: The company supplies a range of infusion pumps and accessories that support continuous patient care.
- Biomedical Services and Repair: InfuSystem provides repair, maintenance, and calibration services for biomedical equipment, ensuring devices operate safely and efficiently.
The Device Solutions business is essential to InfuSystem’s long-term growth strategy. It allows the company to strengthen relationships with medical device partners and healthcare systems while creating a steady revenue stream through rentals, servicing, and equipment sales.
Operational Footprint
InfuSystem operates Centers of Excellence across multiple U.S. states — including Michigan, Kansas, California, Massachusetts, and Texas — as well as in Ontario, Canada. These centers provide localized field support and service capabilities, allowing the company to maintain consistent, high-quality service standards nationwide.
Its nationwide network ensures fast response times and personalized assistance for both patients and healthcare partners. This field-based model is a key differentiator for in a growing healthcare services market that demands flexibility and reliability.
Commitment to Service and Growt
InfuSystem’s mission is to deliver reliable, patient-centered solutions that make advanced treatments more accessible in non-hospital settings. The company’s team collaborates with healthcare providers to ensure patients receive the equipment, education, and support necessary to complete their prescribed therapies successfully.
Over recent years, the comapny has focused on strengthening its infrastructure, streamlining operations, and expanding its relationships with healthcare providers and payers. The dual-platform approach — combining patient care delivery with device management — has positioned the company for continued growth as the U.S. healthcare system increasingly emphasizes outpatient and value-based care models.
Anticipation for Q3 Results
The upcoming third-quarter earnings release is expected to provide updates on the company financial performance, segment growth, and strategic initiatives. While the company has not provided preliminary figures, analysts and investors will likely focus on revenue trends within its Patient Services and Device Solutions platforms, as well as margins, cost management, and cash flow performance.
Management is also expected to share updates on ongoing partnerships and operational efficiencies gained through technology investments and service network enhancements.
Industry Context
The U.S. healthcare industry continues to see rising demand for outpatient and home-based care solutions. This shift has been driven by patient preferences, cost savings for providers, and the growing adoption of remote monitoring and digital healthcare technologies.
integrated model — providing both direct patient services and backend support for device manufacturers — positions it well to capture opportunities in this evolving landscape. The company’s expertise in managing complex therapy programs, combined with its nationwide infrastructure, allows it to deliver scalable solutions that benefit both patients and providers.
